Patents by Inventor Donald G. Comb

Donald G. Comb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11986690
    Abstract: The method of maintaining a first flow rate through a first valve in a fluid delivery system, the fluid delivery system including a and a plurality of fluid valves in fluid communication with the pump, and a controller controlling the pressure generated by the pump and the position of the plurality of valves. The method includes providing the first flow rate of a fluid pressurized by the pump through the first valve, receiving a request for a second flow rate of the fluid through a second valve, determining a predicted effect on the first flow rate based on the request, adjusting at least one of the position of the first valve and the pressure generated by the pump to maintain the first flow rate based on the predicted effect, and adjusting the position of the second valve to provide the second flow rate of the fluid through the second valve.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: May 21, 2024
    Assignee: Elkhart Brass Manufacturing Company, Inc.
    Inventors: Eric N. Combs, Donald E. Sjolin, Frederic J. Einstein, Kevin McGuire, Lee R. Jones, John E. McLoughlin, Neocles G. Athanasiades, Kiam Meng Toh, Kyle A. Stoops
  • Patent number: 6858775
    Abstract: A new type of transgene system is disclosed which allows efficient protein expression in a target host such as a plant, but avoids the undesirable result of the migration of the transgene into related host system and/or to the environment via the pollen. The methods described herein may also be applied to the expression of virtually any protein of interest (e.g. a toxic protein) in eukaryotic (yeast, insect, mammalian cells, etc.) and prokaryotic (E. coli, etc.) organisms.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: February 22, 2005
    Assignee: New England Biolabs, Inc.
    Inventors: Ming-Qun Xu, Thomas C. Evans, Sriharsa Pradhan, Donald G. Comb, Henry Paulus, Luo Sun, Lixin Chen, Inca Ghosh
  • Publication number: 20040096938
    Abstract: A new type of transgene system is disclosed which allows efficient protein expression in a target host such as a plant, but avoids the undesirable result of the migration of the transgene into related host systems and/or to the environment via the pollen. The methods described herein may also be applied to the expression of virtually any protein of interest (e.g. a toxic protein) in eukaryotic (yeast, insect, mammalian cells, etc.) and prokaryotic (E. coli, etc.) organisms.
    Type: Application
    Filed: June 3, 2003
    Publication date: May 20, 2004
    Inventors: Ming-Qun Xu, Thomas C. Evans, Sriharsa Pradhan, Donald G. Comb, Henry Paulus, Luo Sun, Lixin Chen, Inca Ghosh
  • Patent number: 5834247
    Abstract: The present invention is directed to modified proteins and methods of their production. The modified proteins comprise a controllable intervening protein sequence (CIVPS) inserted into or adjacent a target protein, the CIVPS being capable of excision from or cleavage of the modified protein under predetermined conditions in cis or in trans, i.e., increase in temperature, exposure to light, unblocking of amino acid residues by dephosphorylation, treatment with chemical reagents or deglycosylation. If desired, the modified protein can be subjected to these conditions. The CIVPS may also be inserted into a region that substantially inactivates target protein activity. The CIVPS may be used in a number of applications including purification of the target protein in a one-step protocol.
    Type: Grant
    Filed: March 5, 1997
    Date of Patent: November 10, 1998
    Assignee: New England Biolabs, Inc.
    Inventors: Donald G. Comb, Francine B. Perler, William E. Jack, Ming-Qun Xu, Robert A. Hodges, Christopher J. Noren, Shaorong S. C. Chong, Eric Adam, Maurice Southworth
  • Patent number: 5834285
    Abstract: Recombinant DNA polymerases from archaebacteria as well as isolated DNA coding for such polymerases are provided. The isolated DNA is obtained by use or DNA or antibody probes prepared from the DNA encoding T. litoralis DNA polymerase and the T. litoralis DNA polymerase respectively. Also provided are methods for producing recombinant archaebacteria thermostable DNA polymerase and methods for enhancing the expression of such polymerases by identifying, locating and removing introns from within the DNA coding for such DNA polymerases.
    Type: Grant
    Filed: April 4, 1994
    Date of Patent: November 10, 1998
    Assignee: New England Biolabs, Inc.
    Inventors: Donald G. Comb, Francine Perler, Rebecca Kucera, William E. Jack
  • Patent number: 5500363
    Abstract: Recombinant DNA polymerases from archaebacteria as well as isolated DNA coding for such polymerases are provided. The isolated DNA is obtained by use of DNA or antibody probes prepared from the DNA encoding T. litoralis DNA polymerase and the T. litoralis DNA polymerase respectively. Also provided are methods for producing recombinant archaebacteria thermostable DNA polymerase and methods for enhancing the expression of such polymerases by identifying, locating and removing introns from within the DNA coding for such DNA polymerases.
    Type: Grant
    Filed: September 7, 1993
    Date of Patent: March 19, 1996
    Assignee: New England Biolabs, Inc.
    Inventors: Donald G. Comb, Francine Perler, Rebecca Kucera, William E. Jack
  • Patent number: 5496714
    Abstract: The present invention is directed to modified proteins and methods of their production. The modified proteins comprise a controllable intervening protein sequence (CIVPS) inserted into a target protein, the CIVPS being capable of excision from the modified protein under predetermined conditions, i.e., increase in temperature, exposure to light, unblocking of amino acid residues by dephosphorylation or deglycosylation. If desired, the modified protein can be subjected to these conditions. The CIVPS may also be inserted into a region that substantially inactivates target protein activity.
    Type: Grant
    Filed: December 9, 1992
    Date of Patent: March 5, 1996
    Assignee: New England Biolabs, Inc.
    Inventors: Donald G. Comb, Francine B. Perler, William E. Jack, Ming-Qun Xu, Robert A. Hodges
  • Patent number: 5352778
    Abstract: Recombinant DNA polymeraset from archaebacteria as well as isolated DNA coding for such polymeraset are provided. The isolated DNA is obtained by use of DNA or antibody probet prepared from the DNA encoding T. litoralis DNA polymerate and the T. litoralis DNA polymerate respectively. Also provided are meshocs for producing recombinant archaebacteria thermostable DNA polymerase and methods for enhancing the expression of such polymeraset by identifying, locating and removing introns from within the DNA coding for such DNA polymerases.
    Type: Grant
    Filed: December 15, 1993
    Date of Patent: October 4, 1994
    Assignee: New England Biolabs, Inc.
    Inventors: Donald G. Comb, Francine Perler, Rebecca Kucera, William E. Jack
  • Patent number: 5322785
    Abstract: There is provided an extremely thermostable enzyme obtainable from Thermococcus litoralis. The thermostable enzyme has a molecular weight of about 90,000-95,000 daltons, a half-life of about 60 minutes at 100.degree. C. in the absence of stabilizer, and a half-life of about 95 minutes at 100.degree. C. in the presence of stabilizer, such as octoxynol (TRITON X-100) or bovine serum albumin. The thermostable enzyme possesses a 3'-5' proofreading exonuclease activity. The thermostable enzyme may be native or recombinant and may be used for second-strand cDNA synthesis in cDNA cloning, DNA sequencing, and DNA amplification.
    Type: Grant
    Filed: April 17, 1991
    Date of Patent: June 21, 1994
    Assignee: New England Biolabs, Inc.
    Inventors: Donald G. Comb, Francine Perler, Rebecca Kucera, William E. Jack
  • Patent number: 5210036
    Abstract: There is provided an extremely thermostable enzyme obtainable from Thermococcus litoralis. The thermostable enzyme has a molecular weight of about 90,000-95,000 daltons, a half-life of about 60 minutes at 100.degree. C. in the absence of stabilizer, and a half-life of about 95 minutes at 100.degree. C. in the presence of stabilizer, such as octoxynol (TRITON X-100) or bovine serum albumin. The thermostable enzyme possesses a 3'-5' proofreading exonuclease activity. The thermostable enzyme may be native or recombinant and may be used for second-strand cDNA synthesis in cDNA cloning, DNA sequencing, and DNA amplification.
    Type: Grant
    Filed: April 26, 1990
    Date of Patent: May 11, 1993
    Assignee: New England Biolabs, Inc.
    Inventors: Donald G. Comb, Rebecca B. Kucera